BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35238838)

  • 1. The role of genetic testing in prostate cancer screening, diagnosis, and treatment.
    de la Calle CM; Bhanji Y; Pavlovich CP; Isaacs WB
    Curr Opin Oncol; 2022 May; 34(3):212-218. PubMed ID: 35238838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetics of prostate cancer and its utility in treatment and screening.
    Benafif S; Ni Raghallaigh H; McHugh J; Eeles R
    Adv Genet; 2021; 108():147-199. PubMed ID: 34844712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Utility of Germline Genetic Testing in Japanese Men Undergoing Prostate Biopsy.
    Akamatsu S; Terada N; Takata R; Kinoshita H; Shimatani K; Momozawa Y; Yamamoto M; Tada H; Kawamorita N; Narita S; Kato T; Nitta M; Kandori S; Koike Y; Inazawa J; Kimura T; Kimura H; Kojima T; Terachi T; Sugimoto M; Habuchi T; Arai Y; Yamamoto S; Matsuda T; Obara W; Kamoto T; Inoue T; Nakagawa H; Ogawa O
    JNCI Cancer Spectr; 2022 Feb; 6(1):. PubMed ID: 35118230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bringing Prostate Cancer Germline Genetics into Clinical Practice.
    Das S; Salami SS; Spratt DE; Kaffenberger SD; Jacobs MF; Morgan TM
    J Urol; 2019 Aug; 202(2):223-230. PubMed ID: 30730411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic predisposition to prostate cancer.
    Benafif S; Eeles R
    Br Med Bull; 2016 Dec; 120(1):75-89. PubMed ID: 27941040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial Findings from a High Genetic Risk Prostate Cancer Clinic.
    Sessine MS; Das S; Park B; Salami SS; Kaffenberger SD; Kasputis A; Solorzano M; Luke M; Vince RA; Kaye DR; Borza T; Stoffel EM; Cobain E; Merajver SD; Jacobs MF; Milliron KJ; Caba L; van Neste L; Mondul AM; Morgan TM
    Urology; 2021 Oct; 156():96-103. PubMed ID: 34280438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germline and Somatic Mutations in Prostate Cancer for the Clinician.
    Cheng HH; Sokolova AO; Schaeffer EM; Small EJ; Higano CS
    J Natl Compr Canc Netw; 2019 May; 17(5):515-521. PubMed ID: 31085765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate Cancer Germline Variations and Implications for Screening and Treatment.
    Dias A; Kote-Jarai Z; Mikropoulos C; Eeles R
    Cold Spring Harb Perspect Med; 2018 Sep; 8(9):. PubMed ID: 29101112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic testing for hereditary prostate cancer: Current status and limitations.
    Zhen JT; Syed J; Nguyen KA; Leapman MS; Agarwal N; Brierley K; Llor X; Hofstatter E; Shuch B
    Cancer; 2018 Aug; 124(15):3105-3117. PubMed ID: 29669169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate Cancer Screening in a New Era of Genetics.
    Cheng HH; Pritchard CC; Montgomery B; Lin DW; Nelson PS
    Clin Genitourin Cancer; 2017 Dec; 15(6):625-628. PubMed ID: 28697982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer risk, screening and management in patients with germline BRCA1/2 mutations.
    Rajwa P; Quhal F; Pradere B; Gandaglia G; Ploussard G; Leapman MS; Gore JL; Paradysz A; Tilki D; Merseburger AS; Morgan TM; Briganti A; Palapattu GS; Shariat SF
    Nat Rev Urol; 2023 Apr; 20(4):205-216. PubMed ID: 36600087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline genetics of prostate cancer.
    Khan HM; Cheng HH
    Prostate; 2022 Aug; 82 Suppl 1(Suppl 1):S3-S12. PubMed ID: 35657157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personalized prostate cancer screening among men with high risk genetic predisposition- study protocol for a prospective cohort study.
    Margel D; Benjaminov O; Ozalvo R; Shavit Grievink L; Kedar I; Yerushalmi R; Ben-Aharon I; Neiman V; Yossepowitch O; Kedar D; Levy Z; Shohat M; Brenner B; Baniel J; Rosenbaum E
    BMC Cancer; 2014 Jul; 14():528. PubMed ID: 25047061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Inherited Mutations in DNA Repair Genes with Localized Prostate Cancer.
    Lee DJ; Hausler R; Le AN; Kelly G; Powers J; Ding J; Feld E; Desai H; Morrison C; Doucette A; Gabriel P; Genetics Center R; Judy RL; Weaver J; Kember R; Damrauer SM; Rader DJ; Domchek SM; Narayan V; Schwartz LE; Maxwell KN
    Eur Urol; 2022 Jun; 81(6):559-567. PubMed ID: 34711450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial prostate cancer.
    Giri VN; Beebe-Dimmer JL
    Semin Oncol; 2016 Oct; 43(5):560-565. PubMed ID: 27899188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosing hereditary cancer predisposition in men with prostate cancer.
    Pritzlaff M; Tian Y; Reineke P; Stuenkel AJ; Allen K; Gutierrez S; Jackson M; Dolinsky JS; LaDuca H; Xu J; Black MH; Helfand BT
    Genet Med; 2020 Sep; 22(9):1517-1523. PubMed ID: 32439974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study.
    Mitra AV; Bancroft EK; Barbachano Y; Page EC; Foster CS; Jameson C; Mitchell G; Lindeman GJ; Stapleton A; Suthers G; Evans DG; Cruger D; Blanco I; Mercer C; Kirk J; Maehle L; Hodgson S; Walker L; Izatt L; Douglas F; Tucker K; Dorkins H; Clowes V; Male A; Donaldson A; Brewer C; Doherty R; Bulman B; Osther PJ; Salinas M; Eccles D; Axcrona K; Jobson I; Newcombe B; Cybulski C; Rubinstein WS; Buys S; Townshend S; Friedman E; Domchek S; Ramon Y Cajal T; Spigelman A; Teo SH; Nicolai N; Aaronson N; Ardern-Jones A; Bangma C; Dearnaley D; Eyfjord J; Falconer A; Grönberg H; Hamdy F; Johannsson O; Khoo V; Kote-Jarai Z; Lilja H; Lubinski J; Melia J; Moynihan C; Peock S; Rennert G; Schröder F; Sibley P; Suri M; Wilson P; Bignon YJ; Strom S; Tischkowitz M; Liljegren A; Ilencikova D; Abele A; Kyriacou K; van Asperen C; Kiemeney L; ; Easton DF; Eeles RA
    BJU Int; 2011 Jan; 107(1):28-39. PubMed ID: 20840664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatic and Germline Variants Affect Prognosis and Susceptibility in Prostate Cancer.
    Rocca C; Rocca G; Zampieri P; Dell'atti L; Bianchi N; Ippolito C; Aguiari G
    Anticancer Res; 2023 Jul; 43(7):2941-2949. PubMed ID: 37351993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline genetic variants in men with prostate cancer and one or more additional cancers.
    Pilié PG; Johnson AM; Hanson KL; Dayno ME; Kapron AL; Stoffel EM; Cooney KA
    Cancer; 2017 Oct; 123(20):3925-3932. PubMed ID: 28657667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germline Genetics of Prostate Cancer: Time to Incorporate Genetics into Early Detection Tools.
    Fantus RJ; Helfand BT
    Clin Chem; 2019 Jan; 65(1):74-79. PubMed ID: 30459162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.